MCID: EXT010
MIFTS: 49

Extramedullary Plasmacytoma

Categories: Cancer diseases, Immune diseases, Blood diseases

Aliases & Classifications for Extramedullary Plasmacytoma

MalaCards integrated aliases for Extramedullary Plasmacytoma:

Name: Extramedullary Plasmacytoma 12 15 73
Plasmacytoma, Extramedullary 12
Extraosseous Plasmacytoma 12

Classifications:



External Ids:

Disease Ontology 12 DOID:3720
ICD10 33 C90.2 C90.20
NCIt 50 C4002
UMLS 73 C0278619

Summaries for Extramedullary Plasmacytoma

MalaCards based summary : Extramedullary Plasmacytoma, also known as plasmacytoma, extramedullary, is related to plasmacytoma and tonsillitis. An important gene associated with Extramedullary Plasmacytoma is B2M (Beta-2-Microglobulin), and among its related pathways/superpathways are Cytokine Signaling in Immune system and PI3K-Akt signaling pathway. The drugs Bortezomib and Cyclophosphamide have been mentioned in the context of this disorder. Affiliated tissues include bone, bone marrow and colon, and related phenotypes are digestive/alimentary and endocrine/exocrine gland

Related Diseases for Extramedullary Plasmacytoma

Diseases related to Extramedullary Plasmacytoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 129)
# Related Disease Score Top Affiliating Genes
1 plasmacytoma 30.9 B2M IGKC IL2 IL6
2 tonsillitis 30.3 IL2 IL6
3 solitary osseous plasmacytoma 30.2 B2M MYOM2
4 lymphoma, mucosa-associated lymphoid type 29.9 CCND1 IGKC
5 leukemia, chronic lymphocytic 29.3 B2M CCND1 IL2
6 myeloma, multiple 28.8 B2M CCND1 IL2 IL6 MYOM2
7 peritonitis 28.7 B2M IL6
8 thyroiditis 10.4
9 indolent myeloma 10.4 B2M MYOM2
10 non-secretory myeloma 10.3 B2M MYOM2
11 vernal conjunctivitis 10.3 B2M IL2
12 amyloid tumor 10.3 B2M MYOM2
13 b-cell expansion with nfkb and t-cell anergy 10.3 B2M IL2
14 murray valley encephalitis 10.3 IL2 MYOM2
15 mature b-cell neoplasm 10.3 B2M MYOM2
16 hypersensitivity reaction type iv disease 10.3 IL2 MYOM2
17 rheumatic fever 10.2 IL2 MYOM2
18 extramedullary soft tissue plasmacytoma 10.2
19 post-transplant lymphoproliferative disease 10.2 B2M IL6
20 uremic pruritus 10.2 IL2 IL6
21 hemorrhagic fever with renal syndrome 10.2 B2M IL6
22 capillary leak syndrome 10.2 IL2 IL6
23 meningoencephalitis 10.2 B2M IL6
24 microscopic colitis 10.2 IL2 IL6
25 burning mouth syndrome 10.2 IL2 IL6
26 hairy cell leukemia 10.2 CCND1 IL2
27 lymphoma 10.2
28 intermediate uveitis 10.2 IL2 IL6
29 hematopoietic stem cell transplantation 10.1 IL2 IL6
30 exanthem 10.1 IL2 IL6
31 mediastinitis 10.1
32 polyclonal hypergammaglobulinemia 10.1 IL6 MYOM2
33 impetigo 10.1 IL6 MYOM2
34 poems syndrome 10.1 IL6 MYOM2
35 prostatitis 10.1 IL2 IL6
36 osteosclerotic myeloma 10.1 IL6 MYOM2
37 paracoccidioidomycosis 10.1 IL2 IL6
38 sinusitis 10.1
39 nasopharyngitis 10.1
40 cervicitis 10.1
41 pancreatitis 10.1
42 amyloidosis 10.1
43 brucellosis 10.0 IL2 IL6
44 rheumatic heart disease 10.0 IL6 MYOM2
45 tropical spastic paraparesis 10.0 IL2 IL6
46 carpal tunnel syndrome 10.0 B2M IL6
47 adenocarcinoma 10.0
48 spondyloarthropathy 10.0 IL2 IL6
49 chondromyxoid fibroma 10.0 CCND1 CDKN1A
50 conjunctivitis 10.0 IL2 IL6

Graphical network of the top 20 diseases related to Extramedullary Plasmacytoma:



Diseases related to Extramedullary Plasmacytoma

Symptoms & Phenotypes for Extramedullary Plasmacytoma

MGI Mouse Phenotypes related to Extramedullary Plasmacytoma:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 digestive/alimentary MP:0005381 9.65 B2M CCND1 CDKN1A IL2 IL6
2 endocrine/exocrine gland MP:0005379 9.55 IL6 B2M CCND1 CDKN1A IL2
3 neoplasm MP:0002006 9.35 B2M CCND1 CDKN1A IL2 IL6
4 reproductive system MP:0005389 9.02 IL6 B2M CCND1 CDKN1A IL2

Drugs & Therapeutics for Extramedullary Plasmacytoma

Drugs for Extramedullary Plasmacytoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 228)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Bortezomib Approved, Investigational Phase 3,Phase 2,Phase 1 179324-69-7 387447 93860
2
Cyclophosphamide Approved, Investigational Phase 3,Phase 2,Phase 1 50-18-0, 6055-19-2 2907
3
Dexamethasone Approved, Investigational, Vet_approved Phase 3,Phase 2,Phase 1 50-02-2 5743
4
Doxorubicin Approved, Investigational Phase 3,Phase 2,Phase 1 23214-92-8 31703
5
Ketamine Approved, Vet_approved Phase 3 6740-88-1 3821
6
Aspirin Approved, Vet_approved Phase 3 50-78-2 2244
7
Lenalidomide Approved Phase 3,Phase 1 191732-72-6 216326
8
Melphalan Approved Phase 3,Phase 2 148-82-3 4053 460612
9
Prednisone Approved, Vet_approved Phase 3,Phase 2,Phase 1 53-03-2 5865
10
Darbepoetin alfa Approved, Investigational Phase 3,Phase 2 11096-26-7, 209810-58-2
11
Iron Approved Phase 3,Phase 1,Phase 2 7439-89-6 23925
12
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 3 437-38-7 3345
13
Dalteparin Approved Phase 3 9005-49-6
14
Heparin Approved, Investigational Phase 3 9005-49-6 772 46507594
15
Ondansetron Approved Phase 3 99614-02-5 4595
16
Amphotericin B Approved, Investigational Phase 3 1397-89-3 14956 5280965
17
Caspofungin Approved Phase 3,Phase 2 179463-17-3, 162808-62-0 468682 2826718
18
Miconazole Approved, Investigational, Vet_approved Phase 3,Phase 1,Phase 2,Not Applicable 22916-47-8 4189
19
Dextromethorphan Approved Phase 3 125-71-3 5360696 5362449
20
Guaifenesin Approved, Investigational, Vet_approved Phase 3,Not Applicable 93-14-1 3516
21
Morphine Approved, Investigational Phase 3,Not Applicable 57-27-2 5288826
22
Ginseng Approved, Investigational, Nutraceutical Phase 3 50647-08-0
23
St. John's Wort Approved, Investigational, Nutraceutical Phase 3 84082-80-4
24
Doxil Approved June 1999 Phase 3,Phase 2,Phase 1 31703
25 Pancreatic Polypeptide Investigational Phase 3 59763-91-6
26 Alkylating Agents Phase 3,Phase 2,Phase 1
27 Anti-Bacterial Agents Phase 3,Phase 2,Phase 1,Not Applicable
28 Antibiotics, Antitubercular Phase 3,Phase 2,Phase 1,Not Applicable
29 Antiemetics Phase 3,Phase 2,Phase 1
30 Anti-Inflammatory Agents Phase 3,Phase 2,Phase 1
31 Antineoplastic Agents, Alkylating Phase 3,Phase 2,Phase 1
32 Antineoplastic Agents, Hormonal Phase 3,Phase 2,Phase 1
33 Antirheumatic Agents Phase 3,Phase 2,Phase 1,Not Applicable
34 Autonomic Agents Phase 3,Phase 2,Phase 1
35 BB 1101 Phase 3,Phase 2,Phase 1
36 Dexamethasone acetate Phase 3,Phase 2,Phase 1 1177-87-3
37 Gastrointestinal Agents Phase 3,Phase 2,Phase 1
38 glucocorticoids Phase 3,Phase 2,Phase 1
39 HIV Protease Inhibitors Phase 3,Phase 2,Phase 1
40 Hormone Antagonists Phase 3,Phase 2,Phase 1
41 Hormones Phase 3,Phase 2,Phase 1
42 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 3,Phase 2,Phase 1
43 Immunosuppressive Agents Phase 3,Phase 2,Phase 1,Not Applicable
44 Peripheral Nervous System Agents Phase 3,Phase 2,Phase 1,Not Applicable
45
protease inhibitors Phase 3,Phase 2,Phase 1
46 Proteasome Inhibitors Phase 3,Phase 1
47 Topoisomerase Inhibitors Phase 3,Phase 2,Phase 1,Not Applicable
48 Analgesics Phase 3,Not Applicable
49 Anesthetics Phase 3
50 Anesthetics, Dissociative Phase 3

Interventional clinical trials:

(show top 50) (show all 76)
# Name Status NCT ID Phase Drugs
1 CDD Plus Bortezomib or CDDin Relapsed or Refractory Multiple Myeloma With Extramedullary Plasmacytoma Unknown status NCT02336386 Phase 3 CDD;CDD Plus Bortezomib
2 Ketamine Hydrochloride and Best Pain Management in Treating Cancer Patients With Neuropathic Pain Unknown status NCT01316744 Phase 3 ketamine hydrochloride
3 A Study to Compare MPR With MP in Newly Diagnosed Multiple Myeloma Subjects 65 Years Old or Older. Completed NCT00405756 Phase 3 Lenalidomide: Double-blind Induction;Melphalan;Prednisone;Aspirin;Placebo;Lenalidomide: Double-blind Maintenance;Lenalidomide: Open-label
4 A Study of CC-5013 Plus Dexamethasone Versus Dexamethasone Alone in Previously Treated Subjects With Multiple Myeloma Completed NCT00424047 Phase 3 CC-5013 plus dexamethasone;Dexamethasone plus Placebo
5 A Multicenter, Single-Arm, Open-Label Expanded Access Program for Lenalidomide Plus Dexamethasone in Previously Treated Subjects With Multiple Myeloma Completed NCT00478777 Phase 3 Lenalidomide;dexamethasone
6 A Companion Study for Studies THAL-MM-003, CC-5013-MM-009, and CC-5013-MM-010 for Subjects With Multiple Myeloma Completed NCT00622336 Phase 3 Lenalidomide
7 Darbepoetin Alfa With or Without Iron in Treating Anemia Caused By Chemotherapy in Patients With Cancer Completed NCT00661999 Phase 3 sodium ferric gluconate complex in sucrose
8 Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical Trial Completed NCT00750009 Phase 3
9 American Ginseng in Treating Patients With Fatigue Caused by Cancer Completed NCT00719563 Phase 3 American ginseng
10 Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer Pain Completed NCT00666211 Phase 3
11 Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain Completed NCT00538850 Phase 3 Fentanyl sublingual spray;Placebo
12 Darbepoetin Alfa Compared With Epoetin Alfa in Treating Anemia in Patients Receiving Chemotherapy for Cancer Completed NCT00070382 Phase 3 darbepoetin alfa;epoetin alfa
13 St. John's Wort in Relieving Fatigue in Patients Undergoing Chemotherapy or Hormone Therapy for Cancer Completed NCT00005805 Phase 3
14 Dalteparin to Prevent Complications in Cancer Patients Receiving Chemotherapy Through a Catheter Completed NCT00006083 Phase 3 Fragmin
15 Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Treatment Completed NCT00006348 Phase 3 ondansetron
16 Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment Completed NCT00008359 Phase 3 caspofungin acetate;liposomal amphotericin B
17 Liposomal Amphotericin B in Treating Granulocytopenia and Persistent Unexplained Fever in Cancer Patients Completed NCT00003938 Phase 3 liposomal amphotericin B
18 Treatment for Chronic Pain in Patients With Advanced Cancer Completed NCT00003687 Phase 3 dextromethorphan hydrobromide;morphine sulfate
19 Beta Alethine in Treating Patients With Myeloma Unknown status NCT00006466 Phase 1, Phase 2 beta alethine
20 Study of Bortezomib and Dexamethasone With or Without Elotuzumab to Treat Relapsed or Refractory Multiple Myeloma Completed NCT01478048 Phase 2 Bortezomib;Dexamethasone;Dexamethasone;Dexamethasone;Dexamethasone
21 Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer Completed NCT00489203 Phase 2 beclomethasone dipropionate;placebo;tacrolimus;methotrexate
22 Epoetin Alfa or Darbepoetin Alfa in Treating Patients With Anemia Caused by Chemotherapy Completed NCT00416624 Phase 2 darbepoetin alfa;epoetin alfa
23 SWOG-9239 Reduction of Immunosuppression Plus Interferon Alfa and Combination Chemotherapy in Treating Patients With Malignant Tumors That Develop After Organ Transplant Completed NCT00002657 Phase 2 cyclophosphamide;cytarabine;doxorubicin hydrochloride;etoposide;methotrexate;prednisone;vincristine sulfate
24 Donor Natural Killer Cells After Donor Stem Cell Transplant in Treating Patients With Advanced Cancer Completed NCT00823524 Phase 1, Phase 2
25 Epoetin Alfa in Treating Patients With Anemia Who Are Undergoing Chemotherapy for Cancer Completed NCT00255749 Phase 2
26 Interleukin-2 Plus Interferon Alfa in Treating Adults With Metastatic Cancer Completed NCT00002504 Phase 2
27 Busulfan, Fludarabine, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer Completed NCT00245037 Phase 1, Phase 2 busulfan;cyclosporine;fludarabine phosphate;mycophenolate mofetil;Granulocyte colony-stimulating factor (G-CSF);Phenytoin;Methotrexate
28 Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Refractory Cancer Completed NCT00003406 Phase 1, Phase 2 carboplatin;docetaxel;ifosfamide
29 Caspofungin Acetate in Treating Aspergillosis in Patients With Hematologic Cancer or in Patients Who Have Undergone a Stem Cell Transplant Completed NCT00110045 Phase 2 caspofungin acetate
30 Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon Completed NCT00010283 Phase 1, Phase 2 beclomethasone dipropionate
31 Non-Ablative Allo HSCT For Hematologic Malignancies or SAA Completed NCT00006379 Phase 2 cyclophosphamide;fludarabine phosphate
32 Bone Marrow Transplantation in Treating Patients With Hematologic Cancer Completed NCT00005804 Phase 2 cyclophosphamide
33 Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer or Hematologic Cancer Completed NCT00006225 Phase 1, Phase 2
34 Peripheral Blood Lymphocyte Therapy to Prevent Lymphoproliferative Disorders Caused by Epstein-Barr Virus in Patients Who Have Undergone Transplantation Completed NCT00005606 Phase 2
35 Pomalidomide, Ixazomib Citrate, and Dexamethasone in Treating Patients With Previously Treated Multiple Myeloma or Plasma Cell Leukemia Recruiting NCT02547662 Phase 2 Dexamethasone;Ixazomib Citrate;Pomalidomide
36 Short Course Daratumumab in Patients With Multiple Myeloma Recruiting NCT03490344 Phase 2 Daratumumab;Lenalidomide
37 Autologous Stem Cell Transplant Followed By Maintenance Therapy in Treating Elderly Patients With Multiple Myeloma Active, not recruiting NCT01849783 Phase 2 dexamethasone;cisplatin;doxorubicin;cyclophosphamide;etoposide;bortezomib;thalidomide;melphalan
38 Specialized Blood Cell Transplants for Cancers of the Blood and Bone Marrow Active, not recruiting NCT00003838 Phase 2
39 S0340 MRI and Fludeoxyglucose F18 PET in Diagnosing Solitary Plasmacytoma Terminated NCT00109889 Phase 2
40 Velcade Combined With High-Dose Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Terminated NCT00337506 Phase 2 Dexamethasone;velcade
41 Antimicrobial Solution or Saline Solution in Maintaining Catheter Patency and Preventing Catheter-Related Blood Infections in Patients With Malignancies Withdrawn NCT01101412 Phase 1, Phase 2 Edetate Calcium Disodium;Ethanol;Trimethoprim-sulfamethoxazole
42 Combination Chemotherapy Plus Amifostine in Treating Patients With Advanced Cancer Unknown status NCT00004036 Phase 1 amifostine trihydrate;carboplatin;cyclophosphamide
43 Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy Completed NCT00890747 Phase 1 sunitinib malate
44 Imatinib Mesylate in Treating Patients With Advanced Cancer and Liver Dysfunction Completed NCT00025415 Phase 1 imatinib mesylate
45 Japanese Study of BMS-901608 (Elotuzumab) in Combination With Lenalidomide and Low Dose Dexamethasone Completed NCT01241292 Phase 1
46 PS-341 in Treating Patients With Advanced Cancer Completed NCT00006362 Phase 1 bortezomib
47 Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy Completed NCT00005634 Phase 1 vorinostat
48 Decitabine in Treating Patients With Melanoma or Other Advanced Cancer Completed NCT00002980 Phase 1 decitabine
49 Interleukin-12 Followed by Interferon Alfa in Treating Patients With Advanced Cancer Completed NCT00003451 Phase 1
50 Combination Chemotherapy in Treating Patients With Advanced Cancer Completed NCT00003331 Phase 1 fluorouracil;leucovorin calcium;topotecan hydrochloride

Search NIH Clinical Center for Extramedullary Plasmacytoma

Genetic Tests for Extramedullary Plasmacytoma

Anatomical Context for Extramedullary Plasmacytoma

MalaCards organs/tissues related to Extramedullary Plasmacytoma:

41
Bone, Bone Marrow, Colon, Thyroid, Breast, Liver, Pancreas

Publications for Extramedullary Plasmacytoma

Articles related to Extramedullary Plasmacytoma:

(show top 50) (show all 541)
# Title Authors Year
1
Extramedullary plasmacytoma. ( 29496243 )
2018
2
Treatment of relapsed multiple myeloma complicated by cardiac extramedullary plasmacytoma with D-PACE chemotherapy. ( 29523615 )
2018
3
Atypical Presentation of Extramedullary Plasmacytoma. ( 29559881 )
2018
4
Extramedullary plasmacytoma of the trachea: A case report and review of the literature. ( 29504982 )
2018
5
Gastrointestinal manifestations of extramedullary plasmacytoma: a narrative review and illustrative case reports. ( 29692194 )
2018
6
Extramedullary plasmacytoma of the testis: A case report. ( 29204364 )
2018
7
Collet-Sicard Syndrome Attributable to Extramedullary Plasmacytoma of the Jugular Foramen. ( 29191538 )
2018
8
Pattern of care and impact of prognostic factors on the outcome of head and neck extramedullary plasmacytoma: a systematic review and individual patient data analysis of 315 cases. ( 29224044 )
2018
9
Primary extramedullary plasmacytoma of the sigmoid colon with perforation: a case report. ( 29619633 )
2018
10
Extramedullary plasmacytoma: rare neoplasm of parotid gland. ( 29301803 )
2018
11
Uterine Extramedullary Plasmacytoma as a Primary Manifestation of Multiple Myeloma. ( 28834996 )
2017
12
Extramedullary Plasmacytoma Arising From the Anterior Mediastinum. ( 28431708 )
2017
13
Clinical findings in 25 patients with sinonasal or nasopharyngeal extramedullary plasmacytoma in a four-decade single-centre series. ( 28537101 )
2017
14
Management of extramedullary plasmacytoma: Role of radiotherapy and prognostic factor analysis in 55 patients. ( 29142463 )
2017
15
Extramedullary plasmacytoma occuring in ileocecum: A case report and literature review. ( 29390503 )
2017
16
Extramedullary plasmacytoma of the testicle. ( 29205163 )
2017
17
Rare Presentation of Primary Extramedullary Plasmacytoma as Lip Lesion. ( 28409043 )
2017
18
Strategy for the treatment and follow-up of sinonasal solitary extramedullary plasmacytoma: a case series. ( 28793931 )
2017
19
Extramedullary plasmacytoma of the lateral rectus muscle. ( 28267386 )
2017
20
Primary extramedullary plasmacytoma mimicking oral lichen planus. ( 28944756 )
2017
21
An extramedullary plasmacytoma in the kidney of a 14-year-old girl: Case report and review of the literature. ( 28178171 )
2017
22
Extramedullary plasmacytoma mimicking pancreatic cancer: A case report and literature review. ( 28663530 )
2017
23
Marginal zone B-cell lymphoma mimicking extramedullary plasmacytoma and the clinical outcome after treatment. ( 28507591 )
2017
24
Oral extramedullary plasmacytoma in a HIV positive patient. ( 27894848 )
2017
25
Multiple Extramedullary Plasmacytoma in a Setting of Complete Bone Marrow Remission: Food for Thought. ( 29340123 )
2017
26
Solitary Extramedullary Plasmacytoma of the Cricoid Cartilage-Case Report. ( 29230383 )
2017
27
Incidental Discovery of Multiorgan Extramedullary Plasmacytomas in the Setting of Newly Diagnosed Multiple Myeloma and Delayed Hemolytic Transfusion Reaction. ( 28761768 )
2017
28
Extramedullary plasmacytoma in the airway of an HIV-positive child. ( 28834349 )
2017
29
Extramedullary Plasmacytoma of the Oral Cavity in a Young Man: a Case Report. ( 27284562 )
2016
30
Atrophoderma of Pasini and Pierini associated with extramedullary plasmacytoma. ( 27443586 )
2016
31
Multiple primary cutaneous plasmacytoma a decade after a nasal solitary extramedullary plasmacytoma: a puzzling case. ( 27980740 )
2016
32
Apparent diffusion coefficient map of a case of extramedullary plasmacytoma. ( 27200157 )
2016
33
Feline Respiratory Extramedullary Plasmacytoma with Lymph Node Metastasis and Intrahistiocytic Amyloid. ( 28017340 )
2016
34
Primary Extramedullary Plasmacytoma in the Gastroduodenal Canal Associated With Epstein-Barr Virus-Associated Adenocarcinoma of the Stomach: A Case Report. ( 27466321 )
2016
35
Solitary extramedullary plasmacytoma of the colon, rectum and anus. ( 28240504 )
2016
36
Endoscopic ultrasound-fine needle aspiration: A novel way to diagnose a solitary extramedullary plasmacytoma of the liver. ( 27080614 )
2016
37
Extramedullary Plasmacytoma of the Paranasal Sinuses: Combining Surgery with External Radiotherapy. ( 27066407 )
2016
38
Primary Plurifocal Extramedullary Plasmacytoma of Breast. ( 27059937 )
2016
39
Establishment of an innovative staging system for extramedullary plasmacytoma. ( 27717354 )
2016
40
Retroperitoneal laparoscopic management of a solitary extramedullary plasmacytoma associated with human immunodeficiency virus infection: A case report. ( 26870281 )
2016
41
Extramedullary plasmacytoma of the gingiva. ( 26887880 )
2016
42
Solitary Extramedullary Plasmacytoma of the Maxillary Sinus, Progressing to Smoldering Multiple Myeloma with Multifocal Skeletal Involvement, which Resolved Completely Following Chemotherapy Alone. ( 27408443 )
2016
43
Double Extramedullary Plasmacytoma of the Stomach with a Long-term Endoscopic Follow-up. ( 27980257 )
2016
44
Extramedullary Plasmacytoma Mimicking Pancreatic Cancer: An Unusual Presentation. ( 27847663 )
2016
45
Extramedullary Plasmacytoma of the Maxilla Simulating a Maxillary Radicular Cyst: Quick Diagnosis and Management. ( 27054435 )
2016
46
Treatment and outcomes for primary cutaneous extramedullary plasmacytoma: a case series. ( 28050154 )
2016
47
Extramedullary Plasmacytoma of the Gallbladder Detected on Fluorine 18-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography. ( 27761300 )
2016
48
Extramedullary Plasmacytoma Presenting With Acute Airway Compromise, Treated With Emergent Rigid Bronchoscopic Resection. ( 27058726 )
2016
49
Extramedullary Plasmacytoma Diagnosed in an HIV-Positive Patient by an Unusual Clinical Presentation. ( 27980867 )
2016
50
Unusual Cause of Sphenoidal Sinus Mass: Extramedullary Plasmacytoma. ( 27779089 )
2016

Variations for Extramedullary Plasmacytoma

Expression for Extramedullary Plasmacytoma

Search GEO for disease gene expression data for Extramedullary Plasmacytoma.

Pathways for Extramedullary Plasmacytoma

Pathways related to Extramedullary Plasmacytoma according to GeneCards Suite gene sharing:

(show all 30)
# Super pathways Score Top Affiliating Genes
1
Show member pathways
13.03 B2M CCND1 CDKN1A IL2 IL6
2
Show member pathways
12.69 CCND1 CDKN1A IL2 IL6
3
Show member pathways
12.6 B2M CCND1 IL2 IL6
4 12.52 CCND1 CDKN1A IL2 IL6
5
Show member pathways
12.33 CDKN1A IL2 IL6
6
Show member pathways
12.31 CCND1 CDKN1A IL6
7
Show member pathways
12.26 CCND1 CDKN1A IL2 IL6
8
Show member pathways
12.13 CCND1 CDKN1A IGKC IL2 IL6
9 11.96 CCND1 CDKN1A IL2 IL6
10 11.94 CCND1 CDKN1A IL6
11 11.92 CCND1 CDKN1A IL6
12
Show member pathways
11.85 CCND1 CDKN1A IL6
13
Show member pathways
11.82 CDKN1A IL2 IL6
14
Show member pathways
11.79 CCND1 CDKN1A IL6
15 11.71 CCND1 IL2 IL6
16 11.67 CCND1 CDKN1A IL6
17 11.49 CDKN1A IL2 IL6
18 11.47 CCND1 IL2
19
Show member pathways
11.43 B2M IL2
20 11.42 CCND1 CDKN1A
21 11.37 CCND1 IL6
22 11.32 CCND1 CDKN1A
23
Show member pathways
11.3 CCND1 IL2 IL6
24 11.25 CCND1 CDKN1A
25 11.14 CCND1 IL6
26 11.12 CCND1 IL6
27 11.09 CCND1 CDKN1A
28 11.05 IL2 IL6
29 11.04 CCND1 CDKN1A IL6
30 10.63 CCND1 CDKN1A IL2 IL6

GO Terms for Extramedullary Plasmacytoma

Cellular components related to Extramedullary Plasmacytoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 cyclin-dependent protein kinase holoenzyme complex GO:0000307 8.62 CCND1 CDKN1A

Biological processes related to Extramedullary Plasmacytoma according to GeneCards Suite gene sharing:

(show all 14)
# Name GO ID Score Top Affiliating Genes
1 response to drug GO:0042493 9.65 B2M CCND1 CDKN1A
2 immune response GO:0006955 9.56 B2M IGKC IL2 IL6
3 positive regulation of B cell activation GO:0050871 9.54 IGKC IL6
4 positive regulation of tyrosine phosphorylation of STAT protein GO:0042531 9.52 IL2 IL6
5 positive regulation of T cell proliferation GO:0042102 9.51 IL2 IL6
6 animal organ regeneration GO:0031100 9.49 CCND1 CDKN1A
7 positive regulation of B cell proliferation GO:0030890 9.46 CDKN1A IL2
8 retina homeostasis GO:0001895 9.43 B2M IGKC
9 response to organonitrogen compound GO:0010243 9.4 CCND1 CDKN1A
10 response to X-ray GO:0010165 9.37 CCND1 CDKN1A
11 response to corticosterone GO:0051412 9.32 CCND1 CDKN1A
12 cytokine-mediated signaling pathway GO:0019221 9.26 CCND1 CDKN1A IL2 IL6
13 positive regulation of immunoglobulin secretion GO:0051024 9.16 IL2 IL6
14 response to glucocorticoid GO:0051384 8.8 CCND1 CDKN1A IL6

Molecular functions related to Extramedullary Plasmacytoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 cyclin-dependent protein serine/threonine kinase activity GO:0004693 8.62 CCND1 CDKN1A

Sources for Extramedullary Plasmacytoma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....